Immune responses induced by Gene Gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 5163-5169

  Belperron, Alexia A ^a,d   Feltquate, David ^b   Fox, Barbara A ^a   Horii, Toshihiro ^c   Bzik, David J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GENE GUN; IMMUNE RESPONSE; IMMUNIZATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; VACCINATION;

EID: 0032834491     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.5163-5169.1999     Document Type: Article

References (58)

1. Banyal, H. S., and J. Inselburg. 1985. Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies. Am. J. Trop. Med. Hyg. 34:1055-1064.
2. Barr, P. J., J. Inselburg, L. M. Green, J. Kansopon, B. K. Hahm, H. L. Gibson, C. T. Lee-Ng, D. J. Bzik, W.-B. Li, and I. C. Bathurst. 1991. Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents. Mol. Biochem. Parasitol. 45:159-170.
3. Bhatia, A., P. Delplace, B. Fortier, J. F. Dubremetz, and A. Vernes. 1987. Immunochemical analysis of a major antigen of Plasmodium falciparum (P126) among ten geographic isolates. Am. J. Trop. Med. Hyg. 36:15-19.
4. Bonato, V. L. D., V. M. F. Lima, R. E. Tascon, D. B. Lowrie, and C. L. Silva. 1998. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect. Immun. 66:169-175.
5. Bzik, D. J., W.-B. Li, T. Horii, and J. Inselburg. 1987. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. USA 84:8360-8364.
6. Bzik, D. J., W.-B. Li, T. Horii, and J. Inselburg. 1988. Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol. Biochem. Parasitol. 56:185-188.
7. Coppel, R. L., P. E. Crewther, J. G. Culvenor, L. H. Perrin, G. V. Brown, D. J. Kemp, and R. F. Anders. 1988. Variation in p126, a parasitophorous vacuole antigen at Plasmodium falciparum. Mol. Biol. Med. 5:155-166.
8. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847-1851.
9. Davis, H. L., M. Mancini, M. L. Michel, and R. G. Whalen. 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14:910-915.
10. Debrabant, A., and P. Delplace. 1989. Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol. Biochem. Parasitol. 33:151-158.
11. Debrabant, A., P. Maes, P. Delplace, J. F. Dubremetz, A. Tartar, and D. Camus. 1992. Intramolecular mapping of Plasmodium falciparum P126 proteolytic fragments by N-terminal amino acid sequencing. Mol. Biochem. Parasitol. 53:89-95.
12. Delplace, P., J. F. Dubremetz, B. Fortier, and A. Vernes. 1985. A 50 Kd exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum. Mol. Biochem. Parasitol. 17:239-251.
13. Delplace, P., A. Bhatai, M. Cagnard, D. Camus, G. Colombet, A. Debrabant, J. F. Dubremetz, N. Deubreuil, G. Prensier, B. Fortier, A. I. Haq, J. Weber, and A. Vernes. 1988. Protein P126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol. Cell 64:215-221.
14. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66: 1527-1533.
15. Doolan, D. L., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S. L. Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium fulciparum exported protein 1. J. Biol. Chem. 271:17861-17868.
16. Doolan, D. L., R. C. Hedstrom, M. J. Gardner, M. Sedegah, H. Wang, R. A. Gramzinski, M. Margalith, P. Hobart, and S. L. Hoffman. 1998. DNA vaccination as an approach to malaria control: current status and strategies. Curr. Top. Microbiol. Immunol. 226:37-56.
17. Eakin, A. E., J. N. Higaki, J. H. McKerrow, and C. S. Craik. 1989. Cysteine or serine proteinase? Nature 342:132.
18. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and Gene Gun DNA immunization. J. Immunol. 158:2278-2284.
19. Fox, B. A., A. A. Belperron, and D. J. Bzik. Unpublished data.
20. Fox, B. A., and D. J. Bzik. 1994. Analysis of stage specific transcripts of the Plasmodium falciparum serine repeat antigen (SERA) gene and transcription from the SERA locus. Mol. Biochem. Parasitol. 68:133-144.
21. Fox, B. A., P. Xing-Li, K. Suzue, T. Horii, and D. J. Bzik. 1997. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Exp. Parasitol. 85:121-134.
22. Fynan, E. R., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
23. Gramzinski, R. A., D. C. Maris, D. Doolan, Y. Charoenvit, N. Obaldia, R. Rossan, M. Sedegah, R. Wang, P. Hobart, M. Margalith, and S. L. Hoffman. 1997. Malaria DNA vaccines in Aotus monkeys. Vaccine 15:913-915.
24. Halpern, M. D., R. J. Kurlander, and D. S. Pisetsky. 1996. Bacterial DNA induces murine interferon-gamma production by stimulations of IL-12 and tumor necrosis factor-alpha. Cell. Immunol. 167:72-78.
25. Hedstrom, R. C., D. L. Doolan, R. Wang, M. J. Gardner, A. Kumar, M. Sedegah, R. A. Gramzinski, J. B. Sacci, Jr., Y. Charoenvit, W. R. Weiss, J. A. Norman, P. Hobart, and S. L. Hoffman. 1997. The development of a multivalent DNA vaccine for malaria. Springer Semin. Immunopathol. 19:147-159.
26. Hoffman, S. L., D. L. Doolan, M. Sedegah, J. C. Aguiar, R. Wang, A. Malik, R. A. Gramzinski, W. R. Weiss, P. Hobart, J. A. Norman, M. Margalith, and R. C. Hedstrom. 1997. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine 15:842-845.
27. Hoffman, S. L., D. L. Doolan, M. Sedegah, R. Wang, L. F. Scheller, A. Kumar, W. R. Weiss, T. P. Le, D. M. Klinman, P. Hobart, J. A. Norman, and R. C. Hedstrom. 1997. Towards clinical trials of DNA vaccines against malaria. Immunol. Cell Biol. 75:376-381.
28. Horii, T., D. J. Bzik, and J. Inselburg. 1988. Characterization of antigen-expressing Plasmodium falciparum cDNA clones that are reactive with parasite inhibitory antibodies. Mol. Biochem. Parasitol. 30:9-18.
29. Inselburg, J., D. J. Bzik, W.-B. Li, K. M. Green, J. Kansopon, B. K. Hamn, I. C. Bathurst, P. J. Barr, and R. N. Rossan. 1991. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. Infect. Immun. 59:1247-1250.
30. Inselburg, J., I. C. Bathurst, J. Kansopon, G. L. Barchfeld, P. J. Barr, and R. N. Rossan. 1993. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity. Infect. Immun. 61:2041-2047.
31. Inselburg, J., I. C. Bathurst, J. Kansopon, P. J. Barr, and R. Rossan. 1993. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant. Infect. Immun. 61:2048-2052.
32. Johnston, S. A., and D.-C. Tang. 1994. Gene Gun transfection of animal cells and genetic immunization. Methods Cell Biol. 43:353-365.
33. Klinman, D. M., G. Yamshikov, and Y. Ishigatsubo. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:3635-3639.
34. Knapp, B., E. Hundt, U. Nau, and H. A. Kupper. 1989. Molecular cloning, gene structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol. Biochem. Parasitol. 32: 73-88.
35. Kodihalli, S., J. R. Haynes, and H. L. Robinson. 1997. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. Virology 71:3391-3396.
36. Leitner, W. W., M. C. Seguin, W. R. Ballou, J. P. Seitz, A. M. Schultz, M. J. Sheehy, and J. A. Lyon. 1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:6112-6119.
37. Livingston, J. B., S. Lu, H. Robinson, and D. J. Anderson. 1998. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 66:322-329.
38. Lyon, J. A., and J. D. Haynes. 1986. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors. J. Immunol. 136:2245-2251.
39. Lyon, J. A., A. W. Thomas, T. Hal, and J. D. Chulay. 1989. Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol. Biochem. Parasitol. 36:77-86.
40. Manicken, E., R. Rouse, Z. Yum, W. Wire, and B. Rouse. 1995. Genetic immunization against herpes simplex virus. J. Immunol. 155:259-265.
41. Martins, L. P., L. Lau, M. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 64:2574-2582.
42. Michel, M.-L., H. L. Davis, M. Schleef, M. Mancini, P. Tiollais, and R. G. Whalen. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.
43. Mor, G., D. M. Klinman, S. Shapiro, E. Hagiwara, M. Sedegah, I. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155:2039-2046.
44. Morimatsu, K., T. Morikawa, K. Tanabe, D. J. Bzik, and T. Horii. 1997. Sequence diversity in the amino terminal 47 kDa fragment of the Plasmodium falciparum serine repeat antigen. Mol. Biochem. Parasitol. 86:249-254.
45. Pang, X. L., and T. Horii. 1998. Complement-mediated killing of Plasmodium falciparum erythrocytic schizonts with antibodies to the recombinant serine repeat antigen (SERA). Vaccine 16:1299-1305.
46. Pang, X.-L., T. Mitamura, and T. Horii. 1999. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect. Immun. 67:1821-1827.
47. Perkins, M. E. 1986. Stage-dependent processing and localization of a Plasmodium falciparum protein of 130,000 molecular weight. Exp. Parasitol. 65:61-68.
48. Perkins, M. E., and A. Zeifer. 1994. Preferential binding of Plasmodium falciparum SERA and rhoptry proteins to erythrocyte membrane inner leaflet phospholipids. Infect. Immun. 62:1207-1212.
49. Robinson, H. L., D. M. Feltquate, M. J. Morin, J. C. Snatoro, and R. G. Webster. 1997. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNA's. J. Infect. Dis. 176:S50-S55.
50. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
51. Sedegah, M., R. C. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
52. Sugiyama, T., L. Suzue, M. Okamoto, J. Inselburg, K. Tai, and T. Horii. 1996. Production of recombinant SERA proteins of Plasmodium falciparum in Escherichia coli by using synthetic genes. Vaccine 14:1069-1076.
53. Suzue, K., M. Ito, Y. Matsumoto, Y. Tanioka, and T. Horii. 1997. Protective immunity induced in squirrel monkeys with recombinant serine repeat antigen (SERA) of Plasmodium falciparum. Parasitol. Int. 44:17-25.
54. Szarfman. A., D. Walliker, J. S. McBride, J. A. Lyon, I. A. Quakyi, and R. Carter. 1988. Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages. J. Exp. Med. 167:231-236.
55. Ulmer, J. B., J. J. Donnell, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Pery, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
56. Whalen, R. G., and H. L. Davis. 1995-1999, copyright date. [Online.] DNA Vaccine Web-The Paris Ottawa Injection Handbook. http://www.genweb .com/Dnavax/dnavax.html. [18 August 1999, last date accessed.]
57. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. J. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132-140.
58. Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki, and S. H. Growmkowswki. 1993. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:771-776.